{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T18:05:34Z","timestamp":1767204334942,"version":"build-2238731810"},"reference-count":10,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T00:00:00Z","timestamp":1678838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Myocarditis is a rare complication of Coronavirus Disease 2019 (COVID-19) vaccination. We report a case of an elderly female who presented initially with acute myocarditis, fulminant heart failure, and atrial fibrillation after receiving a modified ribonucleic acid (mRNA) vaccine (BNT162b2). Unlike other patients with vaccine-induced myocarditis, she developed persistent fever, sore throat, polyarthralgia, diffuse macular rash, and lymphadenopathy. After extensive investigation, she was diagnosed with post-vaccination Adult-Onset Still's Disease. The systemic inflammation gradually subsided after the use of non-steroidal anti-inflammatory drugs and systemic steroids. She was discharged from hospital with stable hemodynamics. Methotrexate was subsequently given to maintain long-term remission.<\/jats:p>","DOI":"10.3389\/fcvm.2023.1066699","type":"journal-article","created":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T01:38:07Z","timestamp":1678844287000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["RETRACTED: Case report: Coronavirus Disease 2019 (COVID-19) modified RNA vaccination-induced Adult-Onset Still's Disease with fulminant myocarditis as initial presentation"],"prefix":"10.3389","volume":"10","author":[{"given":"Mi","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun Ka","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan Yin Winnie","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung Wah","family":"Siu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixue","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"362","DOI":"10.7326\/M21-3700","article-title":"Carditis after COVID-19 vaccination with a messenger RNA vaccine and an inactivated virus vaccine: a case-control study","volume":"175","author":"Lai","year":"2022","journal-title":"Ann Intern Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1016\/j.jacc.2018.09.072","article-title":"Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations","volume":"72","author":"Ferreira","year":"2018","journal-title":"J Am Coll Cardiol."},{"key":"B3","first-page":"424","article-title":"Preliminary criteria for classification of adult Still's disease","volume":"19","author":"Yamaguchi","year":"1992","journal-title":"J Rheumatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1056\/NEJMc2205667","article-title":"IL-1RA antibodies in myocarditis after SARS-CoV-2 vaccination","volume":"387","author":"Thurner","year":"2022","journal-title":"N Engl J Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1161\/CIRCULATIONAHA.122.061025","article-title":"Circulating spike protein detected in post-COVID-19 mRNA vaccine myocarditis","volume":"225","author":"Yonker","year":"2023","journal-title":"Circulation."},{"key":"B6","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.autrev.2014.01.058","article-title":"Adult-onset Still's disease","volume":"13","author":"Gerfaud-Valentin","year":"2014","journal-title":"Autoimmun Rev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ehjcr\/ytaa127","article-title":"A case report of adult-onset still's disease as a cause of severe mitral regurgitation","volume":"4","author":"Shah","year":"2020","journal-title":"Eur Heart J Case Rep."},{"key":"B8","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1136\/bcr-2022-249290","article-title":"Reactivation of adult-onset Still's disease after use of the COVID-19 ChAdOx1-S vaccine","volume":"15","author":"Ib\u00e1\u00f1ez Vodnizza","year":"2022","journal-title":"BMJ Case Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e21279","DOI":"10.7759\/cureus.21279","article-title":"Adult-onset still's disease after the ChAdOx1 nCoV-19 vaccine","volume":"14","author":"AlQudari","year":"2022","journal-title":"Cureus."},{"key":"B10","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1177\/15353702211070290","article-title":"Hyperinflammation after anti-SARS-CoV-2 mRNA\/DNA vaccines successfully treated with anakinra: case series and literature review","volume":"247","author":"Bindoli","year":"2022","journal-title":"Exp Biol Med."}],"updated-by":[{"DOI":"10.3389\/fcvm.2024.1504298","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T00:00:00Z","timestamp":1728950400000},"record-id":"58205"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1066699\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T07:42:18Z","timestamp":1728978138000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1066699\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,15]]},"references-count":10,"alternative-id":["10.3389\/fcvm.2023.1066699"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2023.1066699","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,15]]},"article-number":"1066699"}}